1. Home
  2. CSGS vs ANIP Comparison

CSGS vs ANIP Comparison

Compare CSGS & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSGS
  • ANIP
  • Stock Information
  • Founded
  • CSGS 1994
  • ANIP 2001
  • Country
  • CSGS United States
  • ANIP United States
  • Employees
  • CSGS N/A
  • ANIP N/A
  • Industry
  • CSGS EDP Services
  • ANIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CSGS Technology
  • ANIP Health Care
  • Exchange
  • CSGS Nasdaq
  • ANIP Nasdaq
  • Market Cap
  • CSGS 1.9B
  • ANIP 2.0B
  • IPO Year
  • CSGS 1996
  • ANIP N/A
  • Fundamental
  • Price
  • CSGS $64.67
  • ANIP $97.71
  • Analyst Decision
  • CSGS Buy
  • ANIP Strong Buy
  • Analyst Count
  • CSGS 8
  • ANIP 9
  • Target Price
  • CSGS $68.86
  • ANIP $86.00
  • AVG Volume (30 Days)
  • CSGS 210.0K
  • ANIP 475.8K
  • Earning Date
  • CSGS 11-05-2025
  • ANIP 11-07-2025
  • Dividend Yield
  • CSGS 1.98%
  • ANIP N/A
  • EPS Growth
  • CSGS 30.24
  • ANIP N/A
  • EPS
  • CSGS 2.89
  • ANIP N/A
  • Revenue
  • CSGS $1,208,376,000.00
  • ANIP $747,399,000.00
  • Revenue This Year
  • CSGS $3.49
  • ANIP $39.32
  • Revenue Next Year
  • CSGS $3.23
  • ANIP $9.62
  • P/E Ratio
  • CSGS $22.43
  • ANIP N/A
  • Revenue Growth
  • CSGS 3.31
  • ANIP 38.68
  • 52 Week Low
  • CSGS $44.57
  • ANIP $52.50
  • 52 Week High
  • CSGS $67.60
  • ANIP $99.50
  • Technical
  • Relative Strength Index (RSI)
  • CSGS 53.77
  • ANIP 75.51
  • Support Level
  • CSGS $63.11
  • ANIP $96.50
  • Resistance Level
  • CSGS $65.85
  • ANIP $99.50
  • Average True Range (ATR)
  • CSGS 1.30
  • ANIP 2.17
  • MACD
  • CSGS 0.09
  • ANIP -0.36
  • Stochastic Oscillator
  • CSGS 66.85
  • ANIP 81.77

About CSGS CSG Systems International Inc.

CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, the company generates revenue from the United States.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: